Sign Up | Log In | What is SocialPicks?

OSI Pharmaceuticals Inc. (OSIP) Trade Now » Rate OSIP - Discuss OSIP - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

N/A

** not enough data to be rated

This Quarter's Sentiment:

All:

90.0%

Top:

100.0%

Rate OSIP:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

OSIP Analysis & Videos »

... View All >

OSIP: Bull or Bear?

Updated Clinical Trial and FDA Decision Calendars OSIP

73%

-6.48%
in 261 days

Below is a summary of updates to the BioMedReports.com database of 241 entries included in the FDA and Clinical Trial Calendars.

http://biomedreports.com/fda-calendar.html

<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 104 entries through 3/20/09. The FDA Calendar includes the following information: company name, ticker, decision date, and descrip...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 03/20/09

Comment

OSI Pharmaceuticals Inc. OSIP

62%

-32.43%
in 460 days

OSI Pharmaceuticals, Inc., a biotechnology company, discovers, develops, and commercializes molecular targeted therapies for oncology, diabetes, and obesity in the United States and internationally. Its flagship product, Tarceva (erlotinib) is a small molecule inhibitor of the epidermal growth factor receptor, which is used for the treatment of advanced non-small cell lung cancer, as well as for the treatment of patients with locally advanced and metastatic pancreatic cancer in combination with the chemotherapy agent, gemcitabine. The company also offers Macugen for the treatment of neovasc...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 09/01/08

Comment

... View All >

People Bullish on OSIP

Mike Havrilla

Principal

73%

8 mos ago

daxpd28

Analyst

82%

10 mos ago

Marian Filo

Principal

62%

about 1 year ago

amob05

Sr. Analyst

21%

over 2 years ago

People Bearish on OSIP

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+71.24%	211
3	stockmarketfunding.com	17.66	+25.60%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.22%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
CSCO	Cisco Systems Inc
GS	Goldman Sachs Group Inc The
GE	General Electric Company
RIO	Companhia Vale Do Rio Doce
XOM	Exxon Mobil Corp
NVDA	NVIDIA Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

StreetInsider.com on OSIP

Form 8-K OSI PHARMACEUTICALS INC For: Nov 16

OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday, December 3rd

OSI Pharma (OSIP) volume and volatility increases into Tarceva committee review

ODAC to Review Using OSI Pharma's (OSIP) Tarceva as First-Line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About OSI Pharmaceuticals Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.